Quest Diagnostics to Speak at U.S. Bancorp Piper Jaffray Health Care Conference
PRNewswire-FirstCall
TETERBORO, N.J.

Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the U.S. Bancorp Piper Jaffray Health Care Conference on Wednesday, January 30, 2002, at The Pierre New York. The Quest Diagnostics presentation is scheduled to begin at 12:00 p.m. Eastern Time.

The conference is being webcast live and can be accessed on the Internet via Real Media at: http://www.on24.com/clients/piperjaffray/conference_020129/index.html?presente r=questdiagno&format=rmmulti

or via Windows Media at: http://www.on24.com/clients/piperjaffray/conference_020129/index.html?presente r=questdiagno&format=wmmulti. A replay of the webcast will be available for 30 days following the conference.

Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: http://www.questdiagnostics.com/.

The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 2000 Form 10-K and subsequent filings.

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X59157131

SOURCE: Quest Diagnostics Incorporated

Contact: Media - Gary Samuels, +1-201-393-5700 or Investors - Cathy
Doherty, +1-201-393-5030, both of Quest Diagnostics Incorporated

Website: http://www.questdiagnostics.com/